The two key biomarkers of, and oncogenic contributors to, Ewing sarcoma, namely EWSR1-Fli1 fusion protein and CD99 expression are linked through miR-30a-5p, which was shown by luciferase assay to bind CD99 [83]. The gene discussed is FLI1; the disease is Ewing sarcoma.